Innitius — Series A (estimated) · €1.8M

Basque women's-health diagnostics startup Innitius closed a €1.8M round co-led by Clave Capital and Nara Capital, with most of its previous investors following on. The money funds R&D and commercial rollout of FineBirth/CerviSense, a torsional-wave plus AI device that assesses cervical consistency to diagnose threatened preterm birth.

LeadClave Capital, Nara Capital RoundSeries A (estimated) Announced15 Feb 2023 CityDerio SectorHealthtech & Bio · Healthtech / Femtech medical devices Source E

Something wrong? Suggest a correction →